0qtjj9ao covaxin reuters - Daily Mail India

Covaxin Phase 2, 3 Clinical Trials For 2-18 Age Group Cleared

The Covaxin trial involves two vaccine doses injected at day 0 and day 28.

New Delhi:

Clinical trials of Covaxin for children from two and 18 years has been cleared by the Drugs Controller General of India (DCGI).

Covaxin maker Bharat Biotech has said the trial will be carried out on “525 healthy volunteers”.

According to a government statement, the drug regulator accepted the recommendation of an expert committee on vaccines.

The trial involves two vaccine doses injected at day 0 and day 28.

Source link

READ ALSO :  India vs New Zealand, WTC Final Live Score, Day 3: Team India Aim To Build On Momentum From Day 2 | Cricket News